Hanerxi Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2014

Location

Suzhou Jiangsu China

Primary Industry

Medical Devices & Equipment

About

Established in 2014 and based in Suzhou, China, Hanerxi is a medical device company focus on the research and development of pen-type syringes. In 2018, the company developed a cartridge-type injection pen. In 2020, it developed a fully automatic injection pen. In August 2024, the firm closed a series A+ funding. The company main business is research, development, production and sales of pen-type syringes. The company products use in the autonomous treatment of chronic diseases such as insulin and growth hormone, precision medicine such as interferon, various cells, genes, biological agents, and cosmetic needles used in consumer medical scenarios.

Current Investors

CCB International, Kunshan Gaoxin Group, Qianhui Capital

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Supplies

Verticals

HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.